Last edition
News about "diabetic peripheral neuropathic pain "
Akums Launches DCGI-Approved Triple-Action Therapy for Diabetic Neuropathic Pain
Akums Drugs & Pharmaceuticals has introduced a DCGI-approved triple-action capsule that combines pregabalin, methylcobalamin and delayed-release duloxetine to offer comprehensive management of diabetic peripheral neuropathic pain while supporting nerve regeneration.
Diabetic Peripheral Neuropathic Pain | 01/07/2026 | By News Bureau | 111
Lexicon Selects Medidata to Advance First Non-Opioid Drug for Neuropathic Pain
Medidata has been chosen by Lexicon Pharmaceuticals, Inc. to help advance PROGRESS, a Phase 2b study of LX9211 in diabetic peripheral neuropathic pain (DPNP), with the potential for LX9211 to become the first new, non-opioid drug approved for neuropathic pain in over two decades.
Diabetic Peripheral Neuropathic Pain | 30/05/2024 | By Aishwarya | 477
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy